OBJECTIVES: It remains unclear whether radiofrequency ablation (RFA) provides comparable outcomes to surgical resection (SR). We, therefore, compared survival outcomes of RFA to SR in patients with early stage and very early stage hepatocellular carcinoma (HCC). METHODS: A multicenter retrospective analysis was performed in patients from five academic hospitals with Barcelona Cancer of the Liver Clinic (BCLC) stages 0-A HCC having RFA or SR as primary therapy. RESULTS: From 2000-2010, 146 patients who received treatment with RFA (n = 96) or SR (n = 52) were identified. In BCLC A patients with
Gory, I., Fink, M. A., Bell, S. J., Gow, P., Nicoll, A. J.
, Knight, V. H., Dev, A. T.
, Rode, A., Bailey, M. J.
, Cheung, W., Kemp, W. W., & Roberts, S. K.
(2015). Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study
. Scandinavian Journal of Gastroenterology
(5), 567 - 576. https://doi.org/10.3109/00365521.2014.953572